Study Stopped
additional recruitment not needed
Real Time Optical Coherence Tomography (OCT) of Human Tissue
1 other identifier
observational
5
1 country
1
Brief Summary
This is a single-arm, prospective, study of an optical imaging device on approximately twenty (20) subjects undergoing lumpectomies at one study site. In vivo and ex vivo imaging will be performed on study subjects with results being compared to final pathology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2012
CompletedFirst Posted
Study publicly available on registry
January 10, 2012
CompletedStudy Start
First participant enrolled
May 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 17, 2019
CompletedJuly 26, 2019
July 1, 2019
1.6 years
January 6, 2012
July 24, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
The sensitivity and specificity of Optical Coherence Tomography to identify whether or not tumor can be identified ex vivo on breast cancer specimens as compared to post-surgical histology conclusions.
One week after surgery
Interventions
Optical coherence tomography will be used to image tissue structure on excised and in vivo specimens.
Eligibility Criteria
Females with breast cancer
You may qualify if:
- Women 18 years of age or older
- Signed ICF
- Women who have been histologically diagnosed with invasive ductal carcinoma or invasive lobular carcinoma of the breast prior to surgery
- Planning breast preservation
- Patients undergoing lumpectomy (partial mastectomy) procedure
You may not qualify if:
- Multicentric disease (histologically diagnosed cancer in two different quadrants of the breast)
- Neoadjuvant systemic therapy
- All T4 tumors
- Previous radiation in the operated breast
- Prior surgical procedure in the same quadrant
- Implants in the operated breast
- Pregnancy
- Lactation
- Participating in any other investigational study for either drug or device which can influence collection of valid data under this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Diagnostic Photonics, Inc.lead
- University of Illinois at Chicagocollaborator
Study Sites (1)
Carle Foundation Hospital
Urbana, Illinois, 61801, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Stephen A Boppart, MD, PhD
University of Illinois and Diagnostic Photonics, Inc.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 6, 2012
First Posted
January 10, 2012
Study Start
May 1, 2012
Primary Completion
December 20, 2013
Study Completion
July 17, 2019
Last Updated
July 26, 2019
Record last verified: 2019-07